top of page
Neuromagen Pharma
NeuroMagen Pharma is developing a novel drug that boosts the effectiveness of telomerase as a neuroprotector in order to delay the onset and progression of ALS.
Company Name | Updating Date | Neurotech Category | Market Category | Target Market | Technologies | Company Founded Year | Company Number of Employees |
|---|---|---|---|---|---|---|---|
Neuromagen Pharma | 02/07/2022 | NeuroPharmacology | NeuroBioTechnology | Biotechnology & Biopharmaceutical | Medical use (pharma, nerve damage rehabilitation, neurodiagnostics. inc. early diagnosis) | Biochemical: pharmacological drugs (Developing drugs) | 01/01/2021 | "1-10" |
bottom of page